NT PHARMA (01011) completed the acquisition of 58.11% equity stake in Zhejiang Kangyuan Medical Devices.

NT PHARMA (01011) announced that it intends to acquire 58.11% equity interest in Zhejiang Kangyuan Medical Equipment for approximately 1.16 billion yuan. The company issued and distributed 275 million new shares to 8 sellers at a price of HK$0.45 per share on March 25, 2026 to complete the payment. All conditions precedent set out in the sale and purchase agreement and supplemental agreement in the "Conditions Precedent" section of the circular have been met. The 100% issued shares of the three target companies (Junbinxiongdi Limited, Yue Hua Limited, and Zhong He Qun Lian Limited) have been transferred and registered under the company's name, making them indirect wholly-owned subsidiaries of the company. After the completion of the acquisition, the company will indirectly hold 58.11% equity interest in Zhejiang Kangyuan Medical Equipment through its wholly-owned subsidiary, and its financial performance will be consolidated into the group's accounts.